These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 19837912

  • 1. 11Beta-hydroxysteroid dehydrogenase type 1 and its role in the hypothalamus-pituitary-adrenal axis, metabolic syndrome, and inflammation.
    Cooper MS, Stewart PM.
    J Clin Endocrinol Metab; 2009 Dec; 94(12):4645-54. PubMed ID: 19837912
    [Abstract] [Full Text] [Related]

  • 2. Glucocorticoids and 11beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome.
    Stimson RH, Walker BR.
    Minerva Endocrinol; 2007 Sep; 32(3):141-59. PubMed ID: 17912154
    [Abstract] [Full Text] [Related]

  • 3. 11beta-hydroxysteroid dehydrogenase type 1 and obesity.
    Morton NM, Seckl JR.
    Front Horm Res; 2008 Sep; 36():146-164. PubMed ID: 18230901
    [Abstract] [Full Text] [Related]

  • 4. Biomarkers of hypothalamic-pituitary-adrenal axis activity in mice lacking 11β-HSD1 and H6PDH.
    Abrahams L, Semjonous NM, Guest P, Zielinska A, Hughes B, Lavery GG, Stewart PM.
    J Endocrinol; 2012 Sep; 214(3):367-72. PubMed ID: 22718432
    [Abstract] [Full Text] [Related]

  • 5. 11-Dehydrocorticosterone causes metabolic syndrome, which is prevented when 11β-HSD1 is knocked out in livers of male mice.
    Harno E, Cottrell EC, Keevil BG, DeSchoolmeester J, Bohlooly-Y M, Andersén H, Turnbull AV, Leighton B, White A.
    Endocrinology; 2013 Oct; 154(10):3599-609. PubMed ID: 23832962
    [Abstract] [Full Text] [Related]

  • 6. Liver-selective transgene rescue of hypothalamic-pituitary-adrenal axis dysfunction in 11beta-hydroxysteroid dehydrogenase type 1-deficient mice.
    Paterson JM, Holmes MC, Kenyon CJ, Carter R, Mullins JJ, Seckl JR.
    Endocrinology; 2007 Mar; 148(3):961-6. PubMed ID: 17170103
    [Abstract] [Full Text] [Related]

  • 7. Intracellular regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase (11beta-HSD)-1 plays a key role in regulation of the hypothalamic-pituitary-adrenal axis: analysis of 11beta-HSD-1-deficient mice.
    Harris HJ, Kotelevtsev Y, Mullins JJ, Seckl JR, Holmes MC.
    Endocrinology; 2001 Jan; 142(1):114-20. PubMed ID: 11145573
    [Abstract] [Full Text] [Related]

  • 8. 11β-Hydroxysteroid dehydrogenase type 1: relevance of its modulation in the pathophysiology of obesity, the metabolic syndrome and type 2 diabetes mellitus.
    Pereira CD, Azevedo I, Monteiro R, Martins MJ.
    Diabetes Obes Metab; 2012 Oct; 14(10):869-81. PubMed ID: 22321826
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target.
    Wamil M, Seckl JR.
    Drug Discov Today; 2007 Jul; 12(13-14):504-20. PubMed ID: 17631244
    [Abstract] [Full Text] [Related]

  • 10. Hypothalamic-pituitary-adrenal axis abnormalities in response to deletion of 11beta-HSD1 is strain-dependent.
    Carter RN, Paterson JM, Tworowska U, Stenvers DJ, Mullins JJ, Seckl JR, Holmes MC.
    J Neuroendocrinol; 2009 Nov; 21(11):879-87. PubMed ID: 19602102
    [Abstract] [Full Text] [Related]

  • 11. 11β-Hydroxysteroid dehydrogenase 1 contributes to the pro-inflammatory response of keratinocytes.
    Itoi S, Terao M, Murota H, Katayama I.
    Biochem Biophys Res Commun; 2013 Oct 18; 440(2):265-70. PubMed ID: 24055708
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tissue production of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 and metabolic disease.
    Walker BR, Andrew R.
    Ann N Y Acad Sci; 2006 Nov 18; 1083():165-84. PubMed ID: 17148739
    [Abstract] [Full Text] [Related]

  • 14. Inhibitors of 11β-hydroxysteroid dehydrogenase type 1 in antidiabetic therapy.
    Wang M.
    Handb Exp Pharmacol; 2011 Nov 18; (203):127-46. PubMed ID: 21484570
    [Abstract] [Full Text] [Related]

  • 15. The role and regulation of 11β-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome.
    Stimson RH, Walker BR.
    Horm Mol Biol Clin Investig; 2013 Sep 18; 15(2):37-48. PubMed ID: 25436731
    [Abstract] [Full Text] [Related]

  • 16. Extra-adrenal regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1: physiological regulator and pharmacological target for energy partitioning.
    Walker BR.
    Proc Nutr Soc; 2007 Feb 18; 66(1):1-8. PubMed ID: 17343766
    [Abstract] [Full Text] [Related]

  • 17. Influence of sub-chronic selective 11β-hydroxysteroid dehydrogenase 1 inhibition on the hypothalamic-pituitary-adrenal axis in female cynomolgus monkeys.
    Hamilton BS, Schoelch C, Schuler-Metz A, Krosky P, Lala DS, Claremon DA, McGeehan GM.
    Eur J Pharmacol; 2016 Oct 15; 789():68-74. PubMed ID: 27393460
    [Abstract] [Full Text] [Related]

  • 18. Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene.
    Iwasaki Y, Takayasu S, Nishiyama M, Tsugita M, Taguchi T, Asai M, Yoshida M, Kambayashi M, Hashimoto K.
    Mol Cell Endocrinol; 2008 Mar 26; 285(1-2):10-8. PubMed ID: 18313835
    [Abstract] [Full Text] [Related]

  • 19. 11beta-Hydroxysteroid Dehydrogenase Type 1 Regulation by Intracellular Glucose 6-Phosphate Provides Evidence for a Novel Link between Glucose Metabolism and Hypothalamo-Pituitary-Adrenal Axis Function.
    Walker EA, Ahmed A, Lavery GG, Tomlinson JW, Kim SY, Cooper MS, Ride JP, Hughes BA, Shackleton CHL, McKiernan P, Elias E, Chou JY, Stewart PM.
    J Biol Chem; 2007 Sep 14; 282(37):27030-27036. PubMed ID: 17588937
    [Abstract] [Full Text] [Related]

  • 20. 11beta-HSD1, inflammation, metabolic disease and age-related cognitive (dys)function.
    Chapman KE, Seckl JR.
    Neurochem Res; 2008 Apr 14; 33(4):624-36. PubMed ID: 17963039
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.